Guillain–Barré and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan

Neurological Sciences

Volumn 37, Issue 11, 2016, Pages 1849-1851

  Fukae, Jiro ^a   Tsugawa, Jun ^a   Ouma, Shinji ^a   Umezu, Tomoko ^a   Kusunoki, Susumu ^b   Tsuboi, Yoshio ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Guillain Barr syndrome; Hepatitis E virus; IgM; Liver dysfunction; Miller Fisher syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GANGLIOSIDE ANTIBODY; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HEPATITIS E; HUMAN; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN CEREBROSPINAL FLUID LEVEL; BLOOD; FEMALE; HEPATITIS E VIRUS; IMMUNOLOGY; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

FEMALE; GUILLAIN-BARRE SYNDROME; HEPATITIS E; HEPATITIS E VIRUS; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; MALE; MIDDLE AGED; MILLER FISHER SYNDROME;

EID: 84978062647     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-016-2644-4     Document Type: Article

References (10)

1. Hughes RA, Cornblath DR (2005) Guillain–Barré syndrome. Lancet 36:1653–1666
2. Teener JW (2012) Miller Fisher’s syndrome. Semin Neurol 32:512–516
3. Lee GY, Poovorawan K, Intharasongkroh D, Sa-Nguanmoo P, Vongpunsawad S, Chirathaworn C, Poovorawan Y (2015) Hepatitis E virus infection: epidemiology and treatment implications. World J Virol 4:343–355
4. Sood A, Midha V, Sood N (2000) Guillain–Barré syndrome with acute hepatitis E. Am J Gastroenterol 95:3667–3668
5. Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, Moonen G, Delwaide J (2009) Guillain–Barré syndrome following hepatitis E. World J Gastroenterol 15(13):1645–1647
6. Cronin S, McNicholas R, Kavanagh E, Reid V, O’Rourke K (2011) Anti-glycolipid GM2-positive Guillain–Barre syndrome due to hepatitis E infection. Ir J Med Sci 180(1):255–257
7. Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B (2012) First case of anti-ganglioside GM1-positive Guillain–Barré syndrome due to hepatitis E virus infection. Infection 40:323–326
8. van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, Dalton HR, Jacobs BC (2014) Guillain–Barré syndrome associated with preceding hepatitis E virus infection. Neurology 82:491–497
9. Higuchi MA, Fukae J, Tsugawa J, Ouma S, Takahashi K, Mishiro S, Tsuboi Y (2015) Dysgeusia in a patient with Guillain–Barré syndrome associated with acute hepatitis E: a case report and literature review. Intern Med 54(12):1543–1546
10. Takahashi M, Tamura K, Hoshino Y, Nagashima S, Yazaki Y, Mizuo H, Iwamoto S, Okayama M, Nakamura Y, Kajii E, Okamoto H (2010) A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol 82(2):271–281